Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation
Hector E Carvallo, Roberto R Hirsch
The current SARS COV2 (COVID 19) pandemic has generated a high number of infections among Health Agents. Around 25% of them have had to leave -temporarily or permanently -their jobs, due to having contracted the disease.
Likewise, numerous deaths have been lamented within this group, which acts as the first defense against this and other pathologies that threaten the individual. All this has happened despite Personal Protective Equipments (PPEs), which makes it essential to optimize -from the pharmacological point of view-these elements, in order to reduce the risk of contagion as much as possible. In this sense, Ivermectin has shown its usefulness against SARS COV2, both in treatment and in prophylaxis. Therefore, this work compiles the characteristics of the group of Health Agents (and their close contacts) from a Buenos Aires Hospital specialized in Infectious Diseases, who resorted to it, as well as the results that were obtained.
References
Alfonso, Rodriguez-Morales, Cardona-Ospina, Gutiérrez-Ocampo, Latin American Network of Coronavirus Disease 2019 Research (LANCOVID 19). Clinical, Laboratory and Imaging Features of COVID-19. A Systematic Review and Meta-Analysis
Baraka, Mahmoud, Marschke, Ivermectin Distribution in the Plasma and Tissues of Patients Infected With Onchocerca Volvulus, Eur J Clin Pharmacol
Carvallo, Hirsch, Ivermectin and Herd Immunity in SARS COV2 Pandemic; from Local Experience to Broader Possibility, Clin Immunol Res
Hamming, Timens, Bulthuis, Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis, J Pathol
Heidary, Gharebaghi, Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen, J Antibiot
Hirsch, Carvallo, Covid 19: Children should be Treated Even in Absence of Symptoms, J Clin Toxicol
Héctor, Roberto, María, Safety and efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against covid 19
Héctor, Roberto, Psaltis, Study of the Efficacy and Safety of Topical Ivermectin + IotaCarrageenan in the Prophylaxis against COVID-19 in Health Personnel, Journal of Biomedical Research and Clinical Investigation
Héctor, Verónica, Estudio de la eficacia y seguridad del uso de ivermectina + iota-carragenina tópicas en la profilaxis de la enfermedad COVID 19 en el personal de salud
Ordóñez, Angulo, Efficacy of Ivermectin in the Treatment of Children Parasitized by Strongyloides Stercoralis, Biomedica
Quan-Xin, Long, Tang, Shi, Clinical and Immunological Assessment of Asymptomatic SARS-CoV-2 Infections, Nat Med
Roberto, Hector, Covid 19 and Ivermectin Prevention and Treatment Update, Inf Dis Trav Med
Sharun, Dhama, Patel, Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Version 2, Ann Clin Microbiol Antimicrob
Xu, Zhong, Deng, High Expression of ACE2 Receptor of 2019-nCoV on the Epithelial Cells of Oral Mucosa, Int J Oral Sci
